Sign inJoin waitlistJoin the waitlist

Casey O'Connell

Medical Director for Anticoagulation Services · University of Southern California/Los Angeles General Medical Center

Credentials: · · · · ·

History

University of Southern California/Los Angeles General Medical Center
2004–2005
Internal Medicine
University of Southern California/Los Angeles General Medical Center
2001–2004
George Washington Univ Sch of Med
1997–2001
Stanford University
1993–1997

Research

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
Journal of Thrombosis and Haemostasis · 2018 · 321 citations
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
The Lancet Oncology · 2015 · 234 citations
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study
Blood · 2020 · 171 citations

Howard Liebman
12 papers
Gail Roboz
9 papers
Ruben Mesa
9 papers
Abdulraheem Yacoub
8 papers
Elizabeth Griffiths
8 papers
Nikolai Podoltsev
8 papers · 2 as a resident
Hagop Kantarjian
7 papers
JI
Jean-Pierre Issa
7 papers
John Mascarenhas
7 papers
Caroline Piatek
6 papers · 4 as a fellow
Guillermo Garcia-Manero
6 papers
Angela Fleischman
5 papers

Clinical trials

Danazol for Treatment of Cytopenias in Patients With Cirrhosis
Principal investigator · Recruiting · Phase 2
University of Southern California
2024–2027
Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms
Principal investigator · Recruiting · Phase 2
University of Southern California
2024–2027
Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent
Principal investigator · Terminated · Phase 2
University of Southern California
2017–2019
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Principal investigator · Recruiting
University of Southern California
2017–2027